GSK

GSK NEWSROOM (405 press releases)

Advanced Filtering & Sorting Options:

Dr. Sven Schneider of Linde AG will become the new CFO of Infineon Technologies AG

PRESS RELEASE -- 14, March 2019

(PRESS RELEASE) MUNICH, 14-Mar-2019 — /EuropaWire/ — Dr. Sven Schneider, who is currently Board Spokesman, CFO and Labor Director at Linde AG, will be the next CFO of Infineon Technologies AG. His appointment has just been voted by Infineon’s Supervisory … Read the full press release

Unilever to acquire the Health Food Drinks portfolio (GSK HFD) of GlaxoSmithKline (GSK) in Asia

PRESS RELEASE -- 4, December 2018

LONDON/ ROTTERDAM, 04-Dec-2018 — /EuropaWire/ — Unilever today announced it has signed an agreement to acquire the Health Food Drinks portfolio (GSK HFD) of GlaxoSmithKline (GSK) in India, Bangladesh and 20 other predominantly Asian markets. The transaction consists of three elements: … Read the full press release

WPP appointed to support GSK Consumer Healthcare’s global Panadol business

PRESS RELEASE -- 19, October 2018

LONDON, 19-Oct-2018 — /EuropaWire/ — Following a competitive pitch process, GSK Consumer Healthcare has appointed WPP to support its global Panadol business. WPP will be responsible for creating integrated creative campaigns and content across advertising, digital, shopper and expert marketing, PR … Read the full press release

Iain Mackay will be GSK’s next Chief Financial Officer (CFO); he also joins GSK Board

PRESS RELEASE -- 14, August 2018

Brentford, United Kingdom, 14-Aug-2018 — /EuropaWire/ — GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Iain Mackay has been appointed GSK’s next Chief Financial Officer (CFO). He has also been appointed as an Executive Director to the GSK Board. Mr Mackay will … Read the full press release

GlaxoSmithKline plc completed the buyout of Novartis’ 36.5% stake in its Consumer Healthcare Joint Venture for $13 billion

PRESS RELEASE -- 5, June 2018

Brentford, UK, 05-Jun-2018 — /EuropaWire/ — GlaxoSmithKline plc (LSE/NYSE: GSK) today announces that it has completed the buyout of Novartis’ 36.5% stake in its Consumer Healthcare Joint Venture for $13 billion (£9.3 billion*). The transaction, which was previously announced on 27 … Read the full press release

GlaxoSmithKline to present comprehensive portfolio of respiratory research and scientific innovation at the American Thoracic Society (ATS) conference

PRESS RELEASE -- 17, May 2018

Brentford, United Kingdom, 17-May-2018 — /EuropaWire/ — GlaxoSmithKline plc (GSK) will present extensive data from across its respiratory portfolio, pipeline and early phase research programmes at the American Thoracic Society (ATS) conference in San Diego, USA, 19-23 May 2018. Data presented … Read the full press release

Wellcome supports rapid response to the new Ebola outbreak in Congo with initial fund of up to £2 million

PRESS RELEASE -- 14, May 2018

LONDON, 14-May-2018 — /EuropaWire/ — Wellcome is making an initial fund of up to £2 million available to support a rapid response to the new Ebola outbreak in the Democratic Republic of Congo (DRC). The pledge comes after the DRC … Read the full press release

Kevin Sin appointed new SVP and Head of Worldwide Business Development for R&D at GSK

PRESS RELEASE -- 20, April 2018

Critical role appointed as part of ongoing activities to strengthen and accelerate the Pharmaceuticals pipeline LONDON, 20-Apr-2018 — /EuropaWire/ — GlaxoSmithKline plc (GSK) today announced the appointment of Kevin Sin as Senior Vice President and Head of Worldwide Business Development for … Read the full press release

GlaxoSmithKline, Innoviva: Landmark IMPACT study shows significant benefits of Trelegy Ellipta for patients with chronic obstructive pulmonary disease (COPD)

PRESS RELEASE -- 20, April 2018

LONDON, 20-Apr-2018 — /EuropaWire/ — Once-daily single inhaler triple therapy superior to Relvar/Breo Ellipta and Anoro Ellipta across multiple endpoints including exacerbations, lung function and quality of life. GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced the … Read the full press release

GSK: We are delighted to start the phase III study and evolve our research programme for belimumab in systemic lupus erythematosus (SLE)

PRESS RELEASE -- 22, March 2018

LONDON, 22-Mar-2018 — /EuropaWire/ — GSK today announced the start of a phase III study investigating Benlysta (belimumab) in combination with rituximab in adult patients with systemic lupus erythematosus (SLE). Belimumab and rituximab have different but potentially complementary mechanisms of action. … Read the full press release